Hikma Pharmaceuticals PLC

BATS-CHIXE:HIKL Stock Report

Market Cap: UK£5.1b

Hikma Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BATS-CHIXE:HIKL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 Aug 24SellUK£885,986Bassam Wael KanaanIndividual45,000UK£20.25

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HIKL?
Owner TypeNumber of SharesOwnership Percentage
State or Government85,3150.0385%
Employee Share Scheme569,5750.257%
Individual Insiders4,581,2082.07%
General Public32,993,62114.9%
Private Companies60,814,69527.4%
Institutions122,703,16155.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 61.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
27.1%
Darhold Ltd.
60,000,000UK£1.4b0%no data
6.46%
BlackRock, Inc.
14,327,053UK£328.4m15.8%0.01%
3.52%
The Vanguard Group, Inc.
7,799,249UK£178.8m2.33%no data
2.14%
Bank Julius Bär & Co Ltd., Asset Management Arm
4,743,166UK£108.7m-0.86%0.41%
2.03%
Mawer Investment Management Ltd.
4,509,759UK£103.4m0%0.29%
1.78%
Boston Partners Global Investors, Inc.
3,951,590UK£90.6m49.2%0.07%
1.53%
Royal London Asset Management Ltd.
3,385,143UK£77.6m12.6%0.12%
1.42%
Employees Provident Fund of Malaysia
3,138,515UK£71.9m4.55%0.2%
1.25%
Jupiter Fund Management Plc
2,771,870UK£63.5m55.4%0.23%
1.24%
Polar Capital Holdings Plc
2,756,621UK£63.2m-4.44%0.27%
1.15%
Baillie Gifford & Co.
2,549,674UK£58.4m-9.58%0.03%
1.15%
Columbia Management Investment Advisers, LLC
2,547,349UK£58.4m-4.28%0.02%
1.06%
Norges Bank Investment Management
2,348,022UK£53.8m16.1%0.01%
1.05%
State Street Global Advisors, Inc.
2,333,880UK£53.5m-1.42%no data
1.04%
HSBC Global Asset Management (UK) Limited
2,314,101UK£53.0m9.1%0.03%
1.03%
Amundi Asset Management SAS
2,284,323UK£52.4m104%0.01%
1%
Legal & General Investment Management Limited
2,225,746UK£51.0m-0.99%0.01%
0.84%
GIC Private Limited
1,860,774UK£42.6m18.7%0.11%
0.82%
Dimensional Fund Advisors LP
1,810,311UK£41.5m-0.39%0.01%
0.77%
Fidelity International Ltd
1,714,943UK£39.3m1.35%0.02%
0.71%
Invesco Ltd.
1,566,531UK£35.9m7.7%0.01%
0.68%
Van Lanschot Kempen Investment Management N.V.
1,506,541UK£34.5m-7.05%0.28%
0.67%
Acadian Asset Management LLC
1,493,401UK£34.2m1.06%0.1%
0.66%
UBS Asset Management AG
1,459,464UK£33.5m-19.4%no data
0.63%
Mazen Samih Darwazah
1,392,222UK£31.9m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 03:27
End of Day Share Price 2025/01/31 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hikma Pharmaceuticals PLC is covered by 37 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kamla SinghAlphaValue
Simon MatherBarclays
Emily FieldBarclays